McKesson’s first quarter results fell short of analyst revenue expectations, with management attributing the shortfall to lower branded pharmaceutical revenu...
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
McKesson (NYSE:MCK) reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and prescription technology businesses, while outlining plans for continued earnings growth in fiscal 20
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 6% year on year ...
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 6% year on year ...
Healthcare distributor and services company McKesson (NYSE:MCK) will be reporting earnings this Thursday afternoon. Here’s what investors should know. McKess...
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including McKesson ...
In the complex, high-stakes machinery of the American healthcare system, few companies are as indispensable—yet as quietly influential—as McKesson Corporation (NYSE: MCK). As of March 18, 2026, McKesson stands not merely as a distributor of pills and medical supplies, but as a sophisticated healthcare services platform that has successfully pivoted from low-margin logistics to high-value [...]
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
What a fantastic six months it’s been for McKesson. Shares of the company have skyrocketed 42.9%, setting a new 52-week high of $988.29. This performance may have investors wondering how to approach the situation.
